Thames Valley Capital Limited
PE/Buy-Out · Maidenhead (United Kingdom)
Sign up free to access full profile and submit your pitch.
About
Thames Valley Capital Limited is a venture capital and private equity firm that specializes in early, late-stage, seed investments, growth capital, growth loans, expansion capital, and bridge loans. The firm invests through its funds. Through TV1 Early Stage Fund, the firm specializes in early-stage and seed investments. It invests in seed deals through to Series A rounds. The firm typically invests between £.05 million ($0.08 million) to £.25 million ($0.41 million) in first investment rounds, and up to a total of £.5 million ($0.82 million) per investment including follow-on financing. It may co-invest with several similar investors in the South East and across the United Kingdom. Through TV2 Bridging Loan Fund, the firm seeks to invest in companies with debt values between £0.5 million ($.82 million) and £5 million ($8.21 million) in businesses that are facing short term financing pressure. It provides growth loans in all sectors that require short term financing. It provides loan for a term of between 6 months and two years with a single bullet repayment at term. The firm will require adequate security against the risk of default and expects bridging loan to be repayable within a two year period. It will take warrants and price these warrants at a premium to market value, usually c.20%. Through TVI 3, it seeks to make investments by way of management buyout or management buy-in in niche businesses. It seeks to acquire businesses with turnover between £.5 million ($0.82 million) and £5 million ($8.21 million). Overall, the firm makes seed funding, larger investments, and growth loans in the range of £.05 million ($0.08 million) and £3 million ($4.93 million). It prefers to hold controlling equity positions in its portfolio companies. The firm prefers to invest over longer term time horizon and hold investments for over five to seven years. Thames Valley Capital Limited was formed in 2008 and is based in Maidenhead, United Kingdom with additional offices in Reading, United Kingdom.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.